With respect to MMP9–1562 C/T promoter polymorphism, our study revealed that the frequency of T-allele was found to be predominant in breast cancer group compared to controls, with a 1.44 folds increased risk for BC. This evidence concerns the gene MMP9 and breast carcinoma.